328 related articles for article (PubMed ID: 24530811)
1. Development and pathomechanisms of cardiomyopathy in very long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice.
Tucci S; Flögel U; Hermann S; Sturm M; Schäfers M; Spiekerkoetter U
Biochim Biophys Acta; 2014 May; 1842(5):677-85. PubMed ID: 24530811
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid β-oxidation.
Tucci S; Herebian D; Sturm M; Seibt A; Spiekerkoetter U
PLoS One; 2012; 7(9):e45429. PubMed ID: 23024820
[TBL] [Abstract][Full Text] [Related]
3. De novo fatty acid biosynthesis and elongation in very long-chain acyl-CoA dehydrogenase-deficient mice supplemented with odd or even medium-chain fatty acids.
Tucci S; Behringer S; Spiekerkoetter U
FEBS J; 2015 Nov; 282(21):4242-53. PubMed ID: 26284828
[TBL] [Abstract][Full Text] [Related]
4. Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.
Tucci S
J Inherit Metab Dis; 2017 May; 40(3):317-323. PubMed ID: 28247148
[TBL] [Abstract][Full Text] [Related]
5. Cardiac tissue citric acid cycle intermediates in exercised very long-chain acyl-CoA dehydrogenase-deficient mice fed triheptanoin or medium-chain triglyceride.
Gaston G; Gangoiti JA; Winn S; Chan B; Barshop BA; Harding CO; Gillingham MB
J Inherit Metab Dis; 2020 Nov; 43(6):1232-1242. PubMed ID: 33448436
[TBL] [Abstract][Full Text] [Related]
6. Medium-chain triglycerides impair lipid metabolism and induce hepatic steatosis in very long-chain acyl-CoA dehydrogenase (VLCAD)-deficient mice.
Tucci S; Primassin S; Ter Veld F; Spiekerkoetter U
Mol Genet Metab; 2010 Sep; 101(1):40-7. PubMed ID: 20580297
[TBL] [Abstract][Full Text] [Related]
7. Food withdrawal lowers energy expenditure and induces inactivity in long-chain fatty acid oxidation-deficient mouse models.
Diekman EF; van Weeghel M; Wanders RJ; Visser G; Houten SM
FASEB J; 2014 Jul; 28(7):2891-900. PubMed ID: 24648546
[TBL] [Abstract][Full Text] [Related]
8. Sexual dimorphism of lipid metabolism in very long-chain acyl-CoA dehydrogenase deficient (VLCAD-/-) mice in response to medium-chain triglycerides (MCT).
Tucci S; Flögel U; Spiekerkoetter U
Biochim Biophys Acta; 2015 Jul; 1852(7):1442-50. PubMed ID: 25887160
[TBL] [Abstract][Full Text] [Related]
9. Prolonged QT interval and lipid alterations beyond β-oxidation in very long-chain acyl-CoA dehydrogenase null mouse hearts.
Gélinas R; Thompson-Legault J; Bouchard B; Daneault C; Mansour A; Gillis MA; Charron G; Gavino V; Labarthe F; Des Rosiers C
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H813-23. PubMed ID: 21685264
[TBL] [Abstract][Full Text] [Related]
10. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
Hisahara S; Matsushita T; Furuyama H; Tajima G; Shigematsu Y; Imai T; Shimohama S
Tohoku J Exp Med; 2015 Apr; 235(4):305-10. PubMed ID: 25843429
[TBL] [Abstract][Full Text] [Related]
11. Molecular and cellular pathology of very-long-chain acyl-CoA dehydrogenase deficiency.
Schiff M; Mohsen AW; Karunanidhi A; McCracken E; Yeasted R; Vockley J
Mol Genet Metab; 2013 May; 109(1):21-7. PubMed ID: 23480858
[TBL] [Abstract][Full Text] [Related]
12. AAV9 gene replacement therapy for respiratory insufficiency in very-long chain acyl-CoA dehydrogenase deficiency.
Zieger M; Keeler AM; Flotte TR; ElMallah MK
J Inherit Metab Dis; 2019 Sep; 42(5):870-877. PubMed ID: 30993714
[TBL] [Abstract][Full Text] [Related]
13. Long-term correction of very long-chain acyl-coA dehydrogenase deficiency in mice using AAV9 gene therapy.
Keeler AM; Conlon T; Walter G; Zeng H; Shaffer SA; Dungtao F; Erger K; Cossette T; Tang Q; Mueller C; Flotte TR
Mol Ther; 2012 Jun; 20(6):1131-8. PubMed ID: 22395529
[TBL] [Abstract][Full Text] [Related]
14. Hepatic and muscular effects of different dietary fat content in VLCAD deficient mice.
Primassin S; Tucci S; Spiekerkoetter U
Mol Genet Metab; 2011 Dec; 104(4):546-51. PubMed ID: 21963783
[TBL] [Abstract][Full Text] [Related]
15. VLCAD deficiency: Follow-up and outcome of patients diagnosed through newborn screening in Victoria.
Evans M; Andresen BS; Nation J; Boneh A
Mol Genet Metab; 2016 Aug; 118(4):282-7. PubMed ID: 27246109
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-IS database.
Pena LD; van Calcar SC; Hansen J; Edick MJ; Walsh Vockley C; Leslie N; Cameron C; Mohsen AW; Berry SA; Arnold GL; Vockley J;
Mol Genet Metab; 2016 Aug; 118(4):272-81. PubMed ID: 27209629
[TBL] [Abstract][Full Text] [Related]
17. Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance.
Xiong D; He H; James J; Tokunaga C; Powers C; Huang Y; Osinska H; Towbin JA; Purevjav E; Balschi JA; Javadov S; McGowan FX; Strauss AW; Khuchua Z
Am J Physiol Heart Circ Physiol; 2014 Feb; 306(3):H326-38. PubMed ID: 24285112
[TBL] [Abstract][Full Text] [Related]
18. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.
Djouadi F; Aubey F; Schlemmer D; Ruiter JP; Wanders RJ; Strauss AW; Bastin J
Hum Mol Genet; 2005 Sep; 14(18):2695-703. PubMed ID: 16115821
[TBL] [Abstract][Full Text] [Related]
19. Fasting-induced oxidative stress in very long chain acyl-CoA dehydrogenase-deficient mice.
Tucci S; Primassin S; Spiekerkoetter U
FEBS J; 2010 Nov; 277(22):4699-708. PubMed ID: 20883455
[TBL] [Abstract][Full Text] [Related]
20. Triheptanoin: long-term effects in the very long-chain acyl-CoA dehydrogenase-deficient mouse.
Tucci S; Floegel U; Beermann F; Behringer S; Spiekerkoetter U
J Lipid Res; 2017 Jan; 58(1):196-207. PubMed ID: 27884962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
